報價延遲最少15分鐘:2025/05/31 21:17 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.569 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.68/0.02
|
|
企業價值
38.40M
|
| 資產負債 |
|
每股賬面淨值
0.40
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
19.36M
|
|
每股收益
0.36
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/31 21:17 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe. |